2022 annual financial data
Alzamend Neuro 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -12,319,535 USD and net income was -12,362,059 USD.
Operating cash flow was -6,613,990 USD.
Get free Alzamend Neuro email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,319,535 USD
- Net income
- -12,362,059 USD
- Operating cash flow
- -6,613,990 USD